Aberrant expression of miRNAs in epilepsy

Area of Science:

• Neuroscience
• Molecular Biology
• Genetics

Background:

• Epilepsy is a neurological disorder characterized by seizures and consciousness alterations, significantly impacting patients' daily lives and health.
• The precise molecular mechanisms underlying epilepsy, including neuronal apoptosis, glial cell regeneration, and immune responses, remain incompletely understood.
• MicroRNAs (miRNAs) are key regulators of cellular processes and have emerged as potential contributors to epilepsy's complex pathophysiology.

Purpose of the Study:

• To review and define the role of miRNAs in the pathophysiology of epilepsy.
• To identify specific miRNAs that are dysregulated in epilepsy.

Main Methods:

• Literature review of studies investigating miRNA expression in animal models of epilepsy and human subjects.
• Analysis of genetic variants within miRNAs and their association with epilepsy risk.

Main Results:

• Several miRNAs, including miR-25-3p, miR-494, miR-139-5p, miR-101a-3p, miR-344a, miR-129, miR-298, and miR-187, were found to be downregulated in epilepsy.
• Conversely, miR-132, miR-146a, miR-181a, and miR-155 showed increased expression in epilepsy.
• Genetic variations in miRNAs can influence an individual's susceptibility to epilepsy.

Conclusions:

• MicroRNAs are significantly involved in the development and progression of epilepsy.
• Understanding miRNA dysregulation offers potential therapeutic targets for epilepsy treatment.